A combined DTaP-IPV vaccine (Tetraxim®/Tetravac®) used as school-entry booster: a review of more than 20 years of clinical and post-marketing experience-Reference-Cited by-同舟云学术

A combined DTaP-IPV vaccine (Tetraxim®/Tetravac®) used as school-entry booster: a review of more than 20 years of clinical and post-marketing experience

Published:2022-08-22 Issue:9 Volume:21 Page:1215-1231
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Huoi Catherine¹,Vargas-Zambrano Juan¹,Macina Denis¹,Vidor Emmanuel¹

Affiliation:

1. Sanofi, Lyon, France

Funder

Sanofi

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2022.2084076

Reference119 articles.

1. The Expanded Programme on Immunization of the World Health Organization

2. WHO. Immunization and vaccine-preventable diseases. [cited 2022 May 4]. Available from: https://www.who.int/data/gho/data/themes/immunization

3. WHO. Polio (Pol3) immunization coverage amonth 1-year-olds (%). [cited 2022 May 4]. Available from: https://www.who.int/data/gho/data/indicators/indicator-details/GHO/polio-(pol3)-immunization-coverage-among-1-year-olds-(-)

4. Pediatric Infectious Disease Group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap?

5. The impact of COVID-19 on routine pediatric vaccination delivery in Brazil

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DTaP-IPV-HB-Hib vaccine (Hexaxim): an update 10 years after first licensure;Expert Review of Vaccines;2023-12-06

2. Battle of Polio eradication in the Western Pacific Region in the transition to COVID-19 endemicity;2022-12-03